Full video transcriptClick to expand
Auto-generated transcript of @daniellenstanton's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Does testosterone make you moody? Let's talk about it. Everyone experiences testosterone differently, but this has been my experience.
- 0:09I have been on testosterone cream, I would say about nine years.
- 0:15Injections only six months. There was a big difference from cream to injections.
- 0:22I like to call it, I get a little testy.
- 0:27Maybe you could say moody but testy.
- 0:31This started at the beginning of the injections. I just noticed that surge in the beginning.
- 0:37While I was on a very low dose, I just felt a slight, like I would get annoyed easily when probably in the past I wouldn't get annoyed.
- 0:49The longer you're on it, your body gets used to it and you don't see kind of the moodiness as much.
- 0:58So I felt like it was very mild but enough that I wanted to share with you and I've had a couple questions about it.
@daniellenstanton's testosterone therapy claims, fact-checked
Quick answer
The mood changes she describes when switching from testosterone cream to injections are consistent with the pharmacokinetic differences between delivery methods, specifically the sharper serum peaks and troughs produced by injectable testosterone compared to transdermal absorption. Testosterone also aromatizes to estradiol, meaning mood symptoms during therapy require evaluation of both androgen and estrogen levels, not testosterone alone. Clinicians managing this transition should consider injection frequency, ester selection, and estradiol monitoring before attributing mood changes solely to patient adjustment.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @daniellenstanton's testosterone therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@daniellenstanton's testosterone therapy claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@daniellenstanton's testosterone therapy claims, fact-checked" from danielle stanton. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The mood changes she describes when switching from testosterone cream to injections are consistent with the pharmacokinetic differences between delivery methods, specifically the sharper serum peaks and troughs produced by injectable testosterone compared to transdermal absorption.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to sheri backhaus hrt hrtiktok perimenopause." In this clip, the useful excerpt is: "Does testosterone make you moody?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The mood changes she describes when switching from testosterone cream to injections are consistent with the pharmacokinetic differences between delivery methods, specifically the sharper serum peaks and troughs produced by injectable testosterone compared to transdermal absorption.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The mood changes she describes when switching from testosterone cream to injections are consistent with the pharmacokinetic differences between delivery methods, specifically the sharper serum peaks and troughs produced by injectable testosterone compared to transdermal absorption. Testosterone also aromatizes to estradiol, meaning mood symptoms during therapy require evaluation of both androgen and estrogen levels, not testosterone alone. Clinicians managing this transition should consider injection frequency, ester selection, and estradiol monitoring before attributing mood changes solely to patient adjustment.
- Injectable testosterone produces sharper peak-and-trough serum levels than transdermal cream, which can affect mood stability during the adjustment period, per pharmacokinetic research on delivery methods.
- A 2020 study by Khera et al. in the Journal of Sexual Medicine found that transdermal testosterone delivery produces more consistent hormone levels than injections, which may explain differences in mood side effect profiles.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Injectable testosterone produces sharper peak-and-trough serum levels than transdermal cream, which can affect mood stability during the adjustment period, per pharmacokinetic research on delivery methods.
- A 2020 study by Khera et al. in the Journal of Sexual Medicine found that transdermal testosterone delivery produces more consistent hormone levels than injections, which may explain differences in mood side effect profiles.
- Testosterone aromatizes to estradiol, so mood changes during testosterone therapy should prompt estradiol monitoring, not just testosterone level checks.
- Injection frequency matters: more frequent smaller injections reduce peak-to-trough variability and may reduce associated mood fluctuations compared to less frequent larger doses.
- A 2019 review by Davis et al. in The Lancet Diabetes and Endocrinology found wide individual variation in response to testosterone therapy in women, supporting her point that experiences differ person to person.
- Early mood changes during testosterone therapy are a clinical signal worth reporting to your prescriber, not necessarily a reason to stop, but not something to dismiss without evaluation either.
- Nine years of testosterone cream use followed by six months of injections is a meaningful data point: long-term hormone therapy requires ongoing monitoring and willingness to adjust delivery method or dosing based on evolving response.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @daniellenstanton actually say?
She said testosterone made her "a little testy" after switching from cream to injections, with irritability showing up early in treatment at a low dose, then fading as her body adjusted over time. That's a pretty measured, personal account. She's not claiming testosterone turns everyone into a rage monster. She's describing a transitional phase she noticed in herself and wanted to be transparent about for people asking similar questions.
Worth noting: she's been on testosterone cream for approximately nine years and injections for only six months. So the moodiness she describes is specifically tied to the delivery method switch, not to testosterone use broadly. That distinction matters, and she actually makes it herself.
Does the science back this up?
Mostly, yes. The mood connection to testosterone is real, but it's more complicated than "more testosterone equals more irritability." The research points to hormonal fluctuations, not sustained high levels, as the more likely culprit for mood disruption.
Injectable testosterone, particularly short-acting esters, creates a peak-and-trough pattern in serum levels that transdermal delivery largely avoids. A 2020 study by Khera et al. in the Journal of Sexual Medicine noted that delivery method significantly affects symptom stability, with transdermal formulations producing more consistent hormone levels. When you move from a cream that delivers steady low-level absorption to injections that spike and drop, you're essentially asking your nervous system to adapt to a new hormonal rhythm. The brain's androgen receptors, especially in limbic areas tied to emotional regulation, are sensitive to that variability. A 2016 review by Zarrouf et al. in the Journal of Psychiatric Practice found that while testosterone can improve mood in hypogonadal patients long-term, the early adjustment phase and fluctuating levels can temporarily worsen irritability in some individuals.
What did they get wrong (or right)?
She got the core observation right. Early irritability during testosterone initiation or delivery-method changes is documented, not imagined. Her framing that "the longer you're on it, your body gets used to it" is also broadly consistent with what the literature shows about adaptation over weeks to months.
What she doesn't address, and this is a gap worth flagging, is that mood changes during testosterone therapy in women can also involve estrogen conversion. Testosterone aromatizes to estradiol, and estrogen shifts have their own significant mood implications. A 2019 study by Davis et al. in The Lancet Diabetes and Endocrinology found that testosterone therapy in women produced measurable improvements in sexual function but noted that individual hormonal responses, including estrogen conversion rates, varied widely. If someone experiences mood symptoms, that hormonal interplay (the testosterone-to-estrogen conversion piece) deserves clinical attention, not just patience.
She also doesn't mention injection timing or frequency, which is a real variable. Weekly versus biweekly injections can produce meaningfully different peak-and-trough curves. That's not a criticism of her experience, but it's clinically relevant context she leaves out.
What should you actually know?
If you're switching from transdermal testosterone to injections and notice mood changes, that's a documented phenomenon, not a sign that testosterone is wrong for you. But it's also not something to just white-knuckle through without telling your prescriber.
Injection frequency, ester type, and dose all affect how pronounced the hormonal swings are. Shorter injection intervals can reduce peak-to-trough variability. A provider who's paying attention should be monitoring both testosterone and estradiol levels, not just checking whether your total testosterone hit a target number. Mood is a clinical signal, not just a personal complaint.
Her personal timeline, nine years on cream, six months on injections, is also a reminder that hormone therapy is a long-term commitment with ongoing adjustments. Anyone selling you a "set it and forget it" version of TRT is not describing how this actually works in practice. Response changes over time, delivery preferences evolve, and regular lab monitoring is not optional.
Bottom line: is this worth watching?
Yes, with caveats. She's sharing a genuine, nuanced personal experience and being clear that it's her own, not a universal rule. The observation about early moodiness with injections is scientifically plausible. What this video can't do, and isn't trying to do, is replace a clinical conversation about why mood changes happen mechanistically or what to do about them. If you're experiencing mood symptoms on testosterone, talk to your prescriber. "My body just needs to adjust" might be true. It also might not be the whole picture.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
danielle stanton · TikTok creator
5.1K views on this video
Replying to @Sheri Backhaus #hrt #hrtiktok #perimenopause #testosteronetherapy #fypシ
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about injectable testosterone produces sharper peak-and-trough serum levels than transdermal cream,?
Injectable testosterone produces sharper peak-and-trough serum levels than transdermal cream, which can affect mood stability during the adjustment period, per pharmacokinetic research on delivery methods.
What does the video say about a 2020 study by khera et al. in the journal?
A 2020 study by Khera et al. in the Journal of Sexual Medicine found that transdermal testosterone delivery produces more consistent hormone levels than injections, which may explain differences in mood side effect profiles.
What does the video say about testosterone aromatizes to estradiol, so mood changes during testosterone therapy?
Testosterone aromatizes to estradiol, so mood changes during testosterone therapy should prompt estradiol monitoring, not just testosterone level checks.
What does the video say about injection frequency matters: more frequent smaller injections reduce peak-to-trough variability?
Injection frequency matters: more frequent smaller injections reduce peak-to-trough variability and may reduce associated mood fluctuations compared to less frequent larger doses.
What does the video say about a 2019 review by davis et al. in the lancet?
A 2019 review by Davis et al. in The Lancet Diabetes and Endocrinology found wide individual variation in response to testosterone therapy in women, supporting her point that experiences differ person to person.
What does the video say about early mood changes during testosterone therapy?
Early mood changes during testosterone therapy are a clinical signal worth reporting to your prescriber, not necessarily a reason to stop, but not something to dismiss without evaluation either.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by danielle stanton, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.